How common are nasal telangiectasia in patients with systemic sclerosis?   

Patient with pulmonary hypertension (mixed group 1, 2, 3), COPD, HFpEF, Raynaud’s phenomenon, UCTD (ANA, PM-Scl, SSA-52kd), and recurrent severe epistaxis requiring cauterization.



Answer from: at Academic Institution